US lawmaker calls for litigation funding disclosures
By Sara Merken
Oct 7 (Reuters) -A federal lawmaker has introduced legislation that would require the disclosure of third-party funding in civil lawsuits.
U.S. Republican Representative Darrell Issa of California on Friday introduced a bill that calls for parties in civil litigation to tell the court and other named parties the identity of third-party that has the right to receive payment that is contingent on the outcome of a case or group or cases.
The bill comes as the litigation funding industry faces continued calls for increased oversight. Critics have long argued the practice promotes unnecessary litigation and undermines transparency in the legal system. The U.S. Chamber of Commerce and others have said disclosures can help determine if financial backers are influencing decisions in cases or have conflicts of interest.
The industry's backers counter that it can level the playing field by covering at least some litigation expenses and promote access to justice.
The measure, which is co-sponsored by Republican Representative Scott Fitzgerald of Wisconsin, would also require the parties to provide a copy to the court and named parties of any agreement creating the contingent right. A copy of the bill, which does not reference litigation was provided to Reuters by Issa's office on Monday.
Litigation funders invest in lawsuits or other legal claims in exchange for a cut of any recoveries. The U.S. litigation funding industry has grown over the past decade to become a $15.2 billion dollar industry.
Several other pieces of federal legislation that have been introduced in recent years that would have required litigation finance disclosure in certain cases did not progress.
A few U.S. states, including Louisiana, Indiana and West Virginia, have recently enacted laws governing the litigation finance industry. Measures in states including Florida and Kansas stalled in their legislatures this year.
More than 100 major companies including Amazon.com, Google, Cisco, Meta, Comcast, Exxon, Zurich, Eli Lilly, Bayer, Ford, Pfizer and Novartis urged the U.S. judiciary last week to adopt a nationwide rule requiring litigation funding disclosure. The group's letter came in advance of a hearing by the judiciary's civil rules committee this week.
The International Legal Finance Association, a Washington, D.C., group, was founded in 2020 to advocate for the commercial funding industry.
"Courts already have the authority to order the disclosure of financing agreements and are in the best position to determine the relevancy of any financing agreement to the merits of the litigation," an association spokesperson said in a statement on Monday.
The bill was referred to the U.S. House of Representatives Judiciary Committee.
Reporting by Sara Merken
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
